We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Argent Biopharma Limited | LSE:RGT | London | Ordinary Share | AU0000326647 | ORD NPV (DI) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 6.00 | 5.00 | 7.00 | 0.00 | 00:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
RNS Number:0199N
ReGen Therapeutics PLC
01 July 2003
REGEN THERAPEUTICS PLC
Notification of shareholding
ReGen Therapeutics plc ("ReGen" or "the Company") announces that on 1 July 2003
it received notification that on 27 June 2003 Jubilee Investment Trust Plc
("Jubilee") sold 2,700,000 shares of ReGen. As a result, Jubilee is now
interested in 12,300,000 shares representing 7.6 % of the issued share capital
of the Company.
1 July 2003
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLEALXFEFNDEFE
1 Year Argent Biopharma Chart |
1 Month Argent Biopharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
